PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

157 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Ji, Y.* et al.: Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 68, 207-219 (2019)
42.
Ma, J.* et al.: A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for non-alcoholic fatty liver disease. Diabetes 68, 1073-1083 (2019)
43.
Ratner, C.* et al.: Long-acting neurotensin synergizes with liraglutide to reverse obesity through a melanocortin-dependent pathway. Diabetes 68, 1329-1340 (2019)
44.
Wittenbecher, C.* et al.: Insulin-like growth factor binding protein 2 (IGFBP-2) and the risk of developing type 2 diabetes. Diabetes 68, 188-197 (2019)
45.
Endesfelder, D. et al.: Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119-130 (2018)
46.
Herder, C.* et al.: A systemic inflammatory signature reflecting crosstalk between innate and adaptive immunity is associated with polyneuropathy: KORA F4/FF4 Study. Diabetes 67, 2434-2442 (2018)
47.
Kim, T.* et al.: Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21. Diabetes 67, 1773-1782 (2018)
48.
Kroeger, J.* et al.: Circulating fetuin - A and risk of type 2 diabetes : A mendelian randomization analysis. Diabetes 67, 1200-1205 (2018)
49.
Maczewsky, J.* et al.: TGR5 activation promotes stimulus-secretion coupling of pancreatic -cells via a PKA-dependent pathway. Diabetes 67, 324-336:db180315 (2018)
50.
Mueller, K.M.* et al.: Erratum. Adipocyte glucocorticoid Receptor deficiency attenuates aging- and HFD-induced obesity and impairs the feeding-fasting transition. Diabetes 2017;66:272-286. Diabetes 67, 343-344 (2018)
51.
Norris, J.M.* et al.: Plasma 25-hydroxyvitamin D concentration and risk of islet autoimmunity. Diabetes 67, 146-154 (2018)
52.
Pfuhlmann, K. et al.: Celastrol-induced weight loss is driven by hypophagia and independent from UCP1. Diabetes 67, 2456-2465 (2018)
53.
Salami, F.* et al.: Reduction in white blood cell, neutrophil, and red blood cell counts related to sex, HLA, and islet autoantibodies in Swedish TEDDY children at increased risk for type 1 diabetes. Diabetes 67, 2329-2336 (2018)
54.
van Zuydam, N.R.* et al.: A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes. Diabetes 67, 1414-1427 (2018)
55.
Adam, J. et al.: Response to comment on Adam et al. Metformin effect on nontargeted metabolite profiles in patients with type 2 diabetes and in multiple murine tissues. Diabetes 2016;65:3776-3785. Diabetes 66, e3-e4 (2017)
56.
Bamberg, F.* et al.: Subclinical disease burden as assessed by whole-body MRI in subjects with prediabetes, subjects with diabetes, and normal control subjects from the general population: The KORA-MRI study. Diabetes 66, 158-169 (2017)
57.
Gao, Y. et al.: Disruption of lipid uptake in astroglia exacerbates diet induced obesity. Diabetes 66, 2555-2563 (2017)
58.
Heni, M. et al.: Hypothalamic and striatal insulin action suppresses endogenous glucose production and may stimulate glucose uptake during hyperinsulinemia in lean but not in overweight men. Diabetes 66, 1797-1806 (2017)
59.
Kabra, U.D. et al.: Direct substrate delivery into mitochondrial-fission deficient pancreatic islets rescues insulin secretion. Diabetes 66, 1247-1257 (2017)
60.
Kahn, C.R.* & Ussar, S.: Response to comment on Ussar et al. Regulation of glucose uptake and enteroendocrine function by the intestinal epithelial insulin receptor. Diabetes 2017;66:886-896. Diabetes 66, e6-e6 (2017)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... ▶▶ ▶▮